Effects of laparoscopic Roux-en-Y gastric bypass on glucose-6 phosphate dehydrogenase activity in obese type 2 diabetics

Surgical Endoscopy

Volumn 26, Issue 3, 2012, Pages 823-830

  Schneider, Andrew M ^a   Rawat, Dhwajbahadur ^a   Weinstein, L Steve ^b   Gupte, Sachin A ^a   Richards, William O ^b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Bariatric; Clinical papers; Endocrinology; Research; Trials

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN A1C;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LAPAROSCOPIC SURGERY; LIVER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANK SUM TEST; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TREATMENT OUTCOME;

EID: 84857047370     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-011-1959-8     Document Type: Article

References (30)

1. DW Haslam WP James 2005 Obesity Lancet 366 9492 1197 1209 16198769 10.1016/S0140-6736(05)67483-1 (Pubitemid 41393598)
2. KG Alberti P Zimmet J Shaw 2005 The metabolic syndrome-a new worldwide definition Lancet 366 1059 1062 16182882 10.1016/S0140-6736(05)67402-8 (Pubitemid 41338752)
3. Alberti KG, Zimmet P, Shaw J (2006) The IDF consensus worldwide definition of the metabolic syndrome. IDF Communications, Brussels
4. SA Gupte 2008 Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases Curr Opin Invest Drugs 9 993 1000 1:CAS:528:DC%2BD1cXhtFKntr7J
5. RS Gupte BC Floyd M Kozicky S George Z Ungvari V Neito MS Wolin SA Gupte 2009 Synergistic activation of glucose-6-phosphate dehydrogenase and NADPH oxidase by src kinase elevates superoxide in type 2 diabetic, zucker fa/fa, rat liver Free Radic Biol Med 47 219 228 19230846 10.1016/j.freeradbiomed.2009.01. 028 1:CAS:528:DC%2BD1MXnsFKlsro%3D
6. J Park HK Rho KH Kim SS Choe YS Lee JB Kim 2005 Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity Mol Cell Biol 25 5146 5157 15923630 10.1128/MCB.25.12.5146-5157.2005 1:CAS:528:DC%2BD2MXlt1Orurs%3D (Pubitemid 40781113)
7. A Torquati R Lutfi N Abumrad WO Richards 2005 Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes melllitus in morbidly obese patients J Gastrointest Surg 9 1112 1118 16269382 10.1016/j.gassur.2005. 07.016 (Pubitemid 41564107)
8. S Kim WO Richards 2010 Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass Ann Surg 251 6 1049 1055 20485144 10.1097/SLA.0b013e3181d9769b
9. A Katsuki Y Sumida E Gabazza S Murashima M Furuta R Araki-Sasaki Y Hori Y Yano Y Adachi 2001 Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes Diabetes Care 24 2 362 365 11213893 10.2337/diacare.24.2.362 1:STN:280: DC%2BD3M7otVShsg%3D%3D (Pubitemid 32119139)
10. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the folin phenol reagent J Biol Chem 193 1 265 267 14907713 1:CAS:528: DyaG38XhsVyrsw%3D%3D
11. A Consoli N Nurjhan F Capani J Gerich 1989 Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM Diabetes 38 5 550 557 2653926 10.2337/diabetes.38.5.550 1:STN:280:DyaL1M3jt1ertA%3D%3D (Pubitemid 19125601)
12. P De Meyts 2004 Insulin and its receptor: structure, function and evolution Bioessays 26 1351 1362 15551269 10.1002/bies.20151 (Pubitemid 39664629)
13. T Wallace D Matthews 2002 The assessment of insulin resistance in man Diabet Med 19 527 534 12099954 10.1046/j.1464-5491.2002.00745.x 1:CAS:528:DC%2BD38Xmt1Ogsrg%3D (Pubitemid 35300672)
14. DM Muoio CD Newgard 2008 Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes Nat Rev Mol Cell Biol 9 193 205 18200017 10.1038/nrm2327 1:CAS:528:DC%2BD1cXitlGnurg%3D (Pubitemid 351301824)
15. JW Lee AH Choi M Ham JW Kim SS Choe J Park GY Lee KH Yoon JB Kim 2011 G6PD up-regulation promotes pancreatic beta-cell dysfunction Endocrinology 152 3 793 803 21248143 10.1210/en.2010-0606 1:CAS:528:DC%2BC3MXktVGrs70%3D
16. H Kawano H Yasue A Kitagawa N Hirai T Yoshida H Soejima S Miyamoto M Nakano H Ogawa 2003 Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men J Clin Endocrinol Metab 88 3190 3195 12843164 10.1210/jc.2002-021603 1:CAS:528:DC%2BD3sXlslait7k%3D (Pubitemid 36877493)
17. JJ Díez P Iglesias 2003 The role of the novel adipocyte-derived hormone adiponectin in human disease Eur J Endocrinol 148 293 300 12611609 10.1530/eje.0.1480293 (Pubitemid 36410714)
18. O Ukkola M Santaniemi 2002 Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 80 696 702 12436346 10.1007/s00109-002- 0378-7 1:CAS:528:DC%2BD38XoslOrsrs%3D (Pubitemid 35352035)
19. B Szepesi R Vegors OE Michaelis JM DeMouy 1975 Long-term effects of starvation-refeeding in the rat Nutr Metab 19 45 54 1226270 10.1159/000175646 1:STN:280:DyaE287ps1Kiuw%3D%3D
20. Semenkovich CF (2007) Disorders of lipid metabolism. In: Goldman L, Ausiello D (eds) Cecil medicine. Saunders, Philadelphia, pp 1546-1555
21. JD McGarry 2002 Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes Diabetes 51 1 7 18 11756317 10.2337/diabetes.51.1.7 1:CAS:528:DC%2BD38Xlt1ejsQ%3D%3D
22. B Batetta RR Bonatesta F Sanna M Putzolu MF Mulas M Collu S Dessì 2002 Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells Cell Prolif 35 143 154 12027950 10.1046/j.1365-2184.2002.00231.x 1:CAS:528:DC%2BD38XlsF2msL0%3D (Pubitemid 34534203)
23. L Meloni MR Manca I Loddo G Cioglia P Cocco A Schwartz S Muntoni L Muntoni 2008 Glucose-6-phosphate dehydrogenase deficiency protests against coronary heart disease J Inherit Metab Dis 31 412 417 18392752 10.1007/s10545-008-0704-5 1:CAS:528:DC%2BD1cXnsVSqurw%3D
24. Y Matsuzaki A Honda 2006 Dehydroepiandrosterone and its derivatives: potentially novel anti-proliferative and chemopreventive agents Curr Pharm Des 12 3411 3421 17017935 10.2174/138161206778194015 1:CAS:528:DC%2BD28XpvF2rtL8%3D (Pubitemid 44375466)
25. Richards WO, Schirmer BD (2007) Morbid obesity. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL (eds) Sabiston textbook of surgery, Chap 17. Saunders, Philadelphia, pp 399-430
26. E Fabbrini RA Tamboli F Magkos PA Marks-Shulman AW Eckhauser WO Richards S Klein NN Abumrad 2010 Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults Gastroenterology 139 2 448 455 20457158 10.1053/j.gastro.2010.04.056
27. S Furukawa T Fujita M Shimabukuro M Iwaki Y Yamada Y Nakajima O Nakayama M Makishima M Matsuda I Shimomura 2004 Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 12 1752 1761 15599400 1:CAS:528:DC%2BD2cXhtFaiur7F (Pubitemid 40385531)
28. K Wellen G Hotamisligil 2005 Inflammation, stress, and diabetes J Clin Invest 115 5 1111 1119 15864338 1:CAS:528:DC%2BD2MXktFSksbY%3D (Pubitemid 40629025)
29. CH Lang C Dobbrescu GJ Bagby 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output Endocrinology 130 43 52 1727716 10.1210/en.130.1.43 1:CAS:528:DyaK38XlslSqtQ%3D%3D
30. SA Shtandel' IR Barilyak NA Kravchun IA Snegurskaya DK Miloslavskii TP Levchenko 2010 Genetic determination of the basic clinical components of the metabolic syndrome Cytol Genet 44 1 46 51 10.3103/S0095452710010093